id: NEW:cannabinoid_use_for_chronic_pain_to_prescription_opioid_misuse
name: Cannabinoid Use for Chronic Pain â†’ Prescription Opioid Misuse
from_node:
  node_id: NEW:cannabinoid_use_for_chronic_pain
  node_name: Cannabinoid Use for Chronic Pain
to_node:
  node_id: prescription_opioid_misuse
  node_name: Prescription Opioid Misuse
direction: negative
category: behavioral
mechanism_pathway:
- 'Step 1: Patients with chronic pain initiate cannabinoid use (CBD or THC-containing
  products) as an alternative or adjunct pain management strategy'
- 'Step 2: Cannabinoids provide analgesic effects through THC and CBD mechanisms,
  with small improvements in pain severity observed particularly for neuropathic pain'
- 'Step 3: A subset of chronic pain patients successfully substitute cannabis products
  for prescription opioid medications'
- 'Step 4: Reduced reliance on prescription opioids decreases opportunities for opioid
  dose escalation, dependence development, and misuse behaviors'
- 'Step 5: The substitution effect results in lower rates of prescription opioid misuse
  among cannabinoid users compared to opioid-only treatment approaches'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'K. Boehnke and D. Clauw 2022. "Cannabinoids for Chronic Pain:
    Translating Systematic Review Findings Into Clinical Action." Annals of Internal
    Medicine.'
  supporting_citations: []
description: Cannabis literature suggests that a subset of persons with chronic pain
  successfully substitute cannabis for pain medications, including opioids. The authors
  note that if a patient is able to substitute cannabis products for opioid medications,
  the risk-benefit calculation is relatively straightforward given the disproportionate
  all-cause mortality associated with opioid use. This substitution effect would logically
  reduce prescription opioid misuse by decreasing overall opioid exposure and dependence.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: THC:CBD ratio
  direction: strengthens
  strength: moderate
  description: Products with comparable THC-to-CBD ratios (1.1:1) and synthetic high
    THC products showed greater pain improvements, potentially enabling greater opioid
    substitution
- name: Pain type
  direction: strengthens
  strength: moderate
  description: Evidence strongest for chronic neuropathic pain; other pain conditions
    had limited supporting data
- name: Route of administration
  direction: strengthens
  strength: weak
  description: Tinctures for breakthrough pain and edibles/capsules for extended relief
    may optimize substitution potential
